Last reviewed · How we verify
NCT06595862: EA-Avatar
Open Pilot Trial Evaluating an Avatar-Guided Intervention for Emerging Adults With Alcohol Use Problems and Suicide Risk
NA trial testing EA-Avatar in Binge Drinking in 10 participants. Participants enrolled and being followed up; not accepting new ones.
31 May 2026
Quick facts
| Lead sponsor | University of Massachusetts, Worcester |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 31 January 2025 |
| Primary completion | 31 May 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- EA-Avatar
Conditions studied
- Binge Drinking — all drugs for Binge Drinking →
- Suicidal Ideation — all drugs for Suicidal Ideation →
Sponsor
University of Massachusetts, Worcester
Who can join
Adults 18 to 29, any sex, with Binge Drinking or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is an open pilot usability trial to test the 1) usability of a newly developed mobile health intervention to help manage suicidal ideation and alcohol use problems and 2) feasibility of research protocols with emerging adults (18-29 year-olds) who present to the emergency department.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06595862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of EA-Avatar
Trials testing the same drug.
- NCT07418047 — Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults · EARLY_PHASE1 · not yet recruiting
Other recruiting trials for Binge Drinking
Currently open trials in the same condition.
- NCT06447350 — Alcohol Consumption: Norms, Identities, & Motivations · NA · recruiting
- NCT06687525 — Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study · recruiting
- NCT06318975 — Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use · NA · recruiting
- NCT05946083 — The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning · Phase 2 · recruiting
- NCT05522075 — Reducing Blood Pressure in Mid-life Adult Binge Drinkers · NA · recruiting
Other University of Massachusetts, Worcester trials
Trials by the same sponsor.
- NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
- NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
- NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
- NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
- NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06595862 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06595862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing